By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



10732 Hawk’s Vista Street

Plantation  Florida  33324  U.S.A.
Phone: n/a Fax: n/a


Start Up

Company News
Neurotrope Announces $15.3 Million Private Placement 11/16/2015 9:31:44 AM
Neurotrope To Conduct Study On Niemann-Pick Type C, A Devastating Rare Pediatric Disease 6/24/2015 6:43:23 AM
Neurotrope To Present Findings Of In-Vitro Studies Of Bryostatin's Effects On Niemann Pick Type C1 Cells At The Annual "Michael, Marcia & Christa Parseghian Scientific Conference" For Niemann-Pick Type C 6/12/2015 6:51:44 AM
Neurotrope Joins National Organization for Rare Disorders (NORD) Corporate Council 4/24/2015 12:12:15 PM
Neurotrope Receives Research Grant From The FRAXA Research Foundation To Fund Pre-Clinical Fragile X Syndrome Behavioral Studies 4/20/2015 10:46:36 AM
Neurotrope Receives FDA Orphan Drug Designation For Bryostatin In The Treatment Of Fragile X Syndrome 4/9/2015 6:20:23 AM
Neurotrope Selects Worldwide Clinical Trials To Commence Services For Phase 2B Trial Of Bryostatin For The Treatment Of Alzheimer's Disease 4/6/2015 6:28:26 AM
Neurotrope Announces Positive Final Results From its Phase 2a Safety Study for the Treatment of Alzheimer's Disease 3/17/2015 7:33:28 AM
Neurotrope Announces Positive Top-Line Results From Its Phase 2a Study Of Bryostatin-1 In Alzheimer's Disease 2/24/2015 6:28:41 AM
Neurotrope Forms Clinical Advisory Board To Support Alzheimer's Disease Program 1/14/2015 7:54:35 AM